C.R.S. Section 12-280-117.5
Continuing education for pharmacy technicians

12–280–101
Public interest - rules 12–280–102
Applicability of common provisions 12–280–103
Definitions - rules 12–280–104
State board of pharmacy - creation - subject to review - repeal of parts 12–280–105
Membership of board - removal - compensation - meetings 12–280–106
Veterinary pharmaceutical advisory committee - creation - appointments - rules - repeal 12–280–107
Rules 12–280–108
Powers and duties - rules 12–280–109
Drugs, devices, and other materials 12–280–110
Publications 12–280–111
Malpractice claims information - not public - exception 12–280–112
Fees 12–280–113
Approval of schools 12–280–114
Licensure, certification, or registration - applicability - applications - licensure and certification requirements - rules 12–280–115
Exemptions from licensure - hospital residency programs - home renal dialysis - research companies 12–280–115.5
Certification of pharmacy technicians - requirements - provisional certification - criminal history record check - rules 12–280–116
Expiration and renewal of licenses, certifications, or registrations 12–280–117
Continuing education - exceptions - inactive status 12–280–117.5
Continuing education for pharmacy technicians - exceptions - inactive status 12–280–118
Prescription drug outlet under charge of pharmacist - rules 12–280–119
Registration of facilities - rules 12–280–120
Compounding - dispensing - sale of drugs and devices - rules - definition 12–280–121
Compounding drugs for office use by a veterinarian - rules - definitions 12–280–122
Limited authority to delegate activities constituting practice of pharmacy to pharmacy interns or pharmacy technicians 12–280–123
Prescription required - exception - dispensing opiate antagonists - selling nonprescription syringes and needles 12–280–124
Labeling - rules 12–280–125
Substitution of prescribed drugs and biological products authorized - when - conditions 12–280–125.3
Pharmacists’ authority - minor prescription adaptions 12–280–125.5
Pharmacists’ authority to dispense chronic maintenance drugs - rules - liability 12–280–125.7
Pharmacists’ authority to prescribe and dispense HIV prevention drugs - definitions - rules 12–280–126
Unprofessional conduct - grounds for discipline 12–280–127
Disciplinary actions 12–280–128
Judicial review 12–280–129
Unlawful acts - civil fines 12–280–130
Unauthorized practice - penalties 12–280–131
New drugs - when sales permissible 12–280–132
Advertising of prescription drug prices 12–280–133
Nonresident prescription drug outlet - registration 12–280–133.5
Nonresident 503B outsourcing facility - registration - requirements - denial, revocation, or suspension - rules 12–280–133.7
Third-party logistics providers - registration - denial, revocation, or suspension - rules 12–280–134
Records 12–280–135
Unused medication - licensed facilities - correctional facilities - reuse - definitions - rules 12–280–136
Confidential agreement to limit practice 12–280–137
Investigations of suspicious drugs 12–280–138
Patient counseling - pharmacists required to perform - patient may decline - rules 12–280–139
Insulin affordability program - record keeping - reimbursement - definitions 12–280–140
Emergency prescription insulin supply - eligibility - record keeping 12–280–141
Prescription drugs - automated pharmacy dispensing system - rules - definition 12–280–142
Epinephrine auto-injector affordability program - record keeping - reimbursement - definitions 12–280–201
Legislative declaration 12–280–202
Definitions 12–280–203
Pharmacy peer health assistance fund - rules 12–280–204
Eligibility - participants 12–280–205
Liability 12–280–206
Immunity 12–280–301
Definitions 12–280–303
Wholesaler registration requirements - rules 12–280–304
Record check 12–280–305
Restrictions on transactions 12–280–306
Records - pedigree - compliance with DQSA 12–280–307
Penalty 12–280–308
Manufacturer, agent, representative, or employee - drug cost information - required - definitions 12–280–401
Legislative declaration 12–280–402
Definitions 12–280–403
Prescription drug use monitoring program - registration required - applications - rules - appropriation - repeal 12–280–404
Program operation - access - rules - definitions 12–280–405
Prescription drug monitoring fund - creation - fee 12–280–406
Violations - penalties 12–280–407
Prescription drug outlets - prescribers - responsibilities - liability 12–280–408
Exemption - waiver 12–280–409
Examination and analysis of prescription drug monitoring program - recommendations to executive director 12–280–501
Written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections 12–280–502
Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients - rules 12–280–601
Definitions 12–280–602
Collaborative pharmacy practice agreements - pharmacist requirements 12–280–603
Rules